nine patients with non-insulin-dependent diabetes ( niddm ) treated with glibenclamide ( 3.5 mg b.i.d . ) participated in this randomized double-blind placebo controlled crossover study to evaluate the effects of granulated guar gum ( 5 g t.i.d . with meals ) on the absorption of glibenclamide and metabolic control and serum lipids .
C0011860
non-insulin-dependent diabetes
C0017628
glibenclamide